TAP M&A – founded in 2014 by Dr. Ron Davidson – is a leading independent investment banking firm for M&A and corporate finance. We focus on M&A activity in the medium-sized business sector in Germany, Switzerland and Austria.
As an enterprising investment banking firm, we have longstanding experience in negotiating and executing transactions that are often unique and always of extreme importance to our clients. Our result-oriented compensation plan ensures our client's objectives are always our top focus.
TAP M&A serves entrepreneurs, corporate organizations, family offices, financial institutions and private equity funds. We are managed by the founding partner and are not part of any larger institution that could create competing interests.
Our founding partner, Dr. Ron Davidson, started his career at KPMG Corporate Finance.
Before founding TAP M&A in 2014 he served as managing director for an investment bank where he was responsible for mid-market M&A transactions.
Along with his track record of more than 50 successful M&A agreements, Dr. Davidson commands extensive analytic skills in the area of corporate finance.
TAP M&A cooperates with PKF Munich, a leading auditing company and member of the international PKF network. In addition we maintain a strong network of partners particularly in Italy, Israel and China.
TAP M&A are experts in executing competitive sell-side merger and acquisition processes for our clients. This includes:
identifying, selecting, and contacting potential buyers
preparing extensive information packages in both English and German, including description of the investment case as well as presentation and interpretation of financial data.
Assisting in data room creation, allowing potential buyers to execute due diligence at a later stage of the process and
negotiating Sales and Purchase Agreements through final signing.
TAP M&A has advised on the sale of the Center for Human Genetics and Laboratory Diagnostics based in Martinsried (Germany) to the listed Swedish Medicover Group. The sellers were comprehensively advised and a competitive auction process organized. The laboratory founded in 1998 has a strong position within genetic testing, pathology, transfusion medicine, microbiology and virology. The acquisition allows Medicover to expand its diagnostic offering within these areas and creates a platform for further expansion in southern Germany. The transaction is subject to merger control clearance and regulatory approvals.
We support entrepreneurs, corporate entities, family offices, financial institutions and private equity funds with buy-side advice. Our clients benefit from our experience in
identifying and contacting potential target companies
analyzing potential takeover candidates, particularly in view of finances and
evaluating companies with an added focus on potential synergies.
Moreover, we can also assist in deal
We assist clients with debt structuring and equity financing such as:
acquisition financing or
Our independence ensures no conflict of interests - we can negotiate the best possible solution for our clients.
Our wide range of services also includes:
preparation of a business plan
debt capacity analysis
draft of financing memorandums as well as
selection of institutional investors or banks and negotiation of financing conditions.
Our clients benefit from our excellent contacts with leading institutional investors, family offices and banks as well as our transaction-management capabilities.
Please contact us for more Information or in case of interest.
Phone: +49 89 290 322 71
By providing your contact details, you give your consent that your data will be used for information purposes within the TAP M & A GmbH. We will not give your data to third parties. If you would like to have that information deleted from our records, please notify us by Email at email@example.com.